​​Elsevier’s ClinicalKey AI wins third consecutive AI Innovation Award from Medtech Breakthrough Award program​

Elsevier’s ClinicalKey AI has been awarded the MedTech Breakthrough Award for AI Innovation, a program which recognizes the most innovative products in the global digital health market. This is the third consecutive year ClinicalKey AI has won this award since it was launched in February 2024.

ClinicalKey AI is a clinical decision support solution that delivers the latest clinical information at the point of care within the clinical workflow. It combines trusted, evidence-based clinical content with conversational search powered by generative AI and has been recently enhanced with more content, workflow enhancements, and transparency features for confidence and clarity.

In addition to SMART on FHIR integration, new API capabilities allow ClinicalKey AI to be directly added into an organization’s workflow solutions. Accessibility features include native voice-to-text dictation, adult and pediatric toggling for population-focused results and CME credits and MOC for select boards. Clinicians can access subscription resources available at their institution for Elsevier and non-Elsevier content that may be cited in the response through the Link Resolver feature.

Omry Bigger, President of Clinical Solutions at Elsevier said: “It’s a great honor to accept this award from MedTech Breakthrough. Since launching ClinicalKey AI, we’ve made continuous improvements to respond to the needs of our customers. Winning this award reflects the continuous improvements we’ve made to expand the product’s content, reliability and traceability, ensuring clinicians get trusted information quickly when they need it most.”

To expand the evidence-based sources that power AI responses in the tool, ClinicalKey AI has doubled the volume of full-text journal articles and tripled the number of guidelines sets. Society guidelines from multiple specialties have also been incorporated for discipline-specific information, like the American College of Cardiology, the American College of Emergency Physicians, and more.

Steve Johansson, Managing Director at MedTech Breakthrough said “This innovative clinical decision support tool helps transform complexity into clarity. It is vital that AI-powered tools properly support clinicians to provide high-quality patient care and that they are easy to access, provide clear answers, ensure traceability and allow for deeper investigation. ClinicalKey AI helps clinicians navigate complex questions, enhance decision-making at the point of care, and advances safer, more effective patient care across specialties – many congratulations on your third AI Innovation Award win.”

This is the 10^th annual MedTech Breakthrough Awards, conducted by MedTech Breakthroughopens in new tab/window, an independent market intelligence organization that recognizes the most innovative companies, products and technologies in the health technology market.

關於 Elsevier

身為科學資訊與分析的全球領導者，Elsevier 協助研究人員與醫療照護專業人員推動科學發展，改善醫療成果，造福社會。我們以可信賴、以實證為基礎的內容和先進的 AI 數位技術為基礎，透過創新的解決方案促進洞察力和關鍵決策。

140 多年來，我們一直為研究和醫療保健界的工作提供支援。我們全球 9,500 名員工，包括 2,300 名技術人員，致力於支援研究人員、圖書館館長、學術領袖、資金提供者、政府、研發密集型公司、醫生、護士、未來醫療保健專業人員和教育工作者的重要工作。我們的 2,900 種科學期刊和經典參考工具書包括其領域中最重要的書籍，包括 Cell Press、The Lancet 和 Gray's Anatomy。 我們與愛思唯爾基金會 (Elsevier Foundationopens in new tab/window) 合作，與我們服務的社群攜手合作，在發展中國家和世界各地的科學、研究和醫療保健領域推動包容性和多樣性。 Elsevier 是 RELXopens in new tab/window 的一部分，RELXopens in new tab/window 是一家為專業和商業客戶提供以資訊為基礎的分析和決策工具的全球供應商。有關我們的工作、數位解決方案和內容的更多資訊，請造訪 www.elsevier.com 。